Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1996-12-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.93.25.14821PMID 8962139PMCID PMC26220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism

  1995cited by this paper
• A Neutral Galactocerebroside Sulfate Sulfatidase from Mouse Brain (*)

  1995cited by this paper
• Molecular genetics of metachromatic leukodystrophy

  1994cited by this paper
• Structure of the mouse arylsulfatase A gene and cDNA.

  1994cited by this paper
• Functional compartments of sulphatide metabolism in cultured living cells: evidence for the involvement of a novel sulphatide-degrading pathway.

  1994cited by this paper
• Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease.

  1994cited by this paper
• Targeted disruption of the M(r) 46,000 mannose 6‐phosphate receptor gene in mice results in misrouting of lysosomal proteins.

  1993cited by this paper
• High residual arylsulfatase A (ARSA) activity in a patient with late-infantile metachromatic leukodystrophy.

  1993cited by this paper
• Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease

  1992cited by this paper
• Molecular basis of different forms of metachromatic leukodystrophy.

  1991cited by this paper
• Molecular genetics of metachromatic leukodystrophy

  1991cited by this paper
• Oligodendrocyte cell surface recognized by a novel monoclonal antibody specific to sulfatide.

  1990cited by this paper
• Oligodendrocyte cell surface recognized by a novel monoclonal antibody specific to sulfatide.

  1990cited by this paper
• Lysosulfatide (Sulfogalactosylsphingosine) Accumulation in Tissues from Patients with Metachromatic Leukodystrophy

  1990cited by this paper
• Molecular cloning : a laboratory manual. Cold Spring Harbor, NY

  1989cited by this paper
• Functions of sphingolipids and sphingolipid breakdown products in cellular regulation.

  1989cited by this paper
• Establishment, characterization, and evolution of cultures enriched in type‐2 astrocytes

  1988cited by this paper
• HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells

  1987cited by this paper
• Auditory evoked brainstem response and high‐performance liquid chromatography sulfatide assay as early indices of metachromatic leukodystrophy

  1981cited by this paper
• Proteoglycan-collagen arrangements in developing rat tail tendon. An electron microscopical and biochemical investigation.

  1981cited by this paper
• Spatial Localization Does Not Require the Presence of Local Cues

  1981cited by this paper
• Neuronal depletion of cerebellum in late infantile metachromatic leukodystrophy.

  1980cited by this paper
• Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines.

  1980cited by this paper
• SPECIFIC STAINING OF SULPHATE GROUPS WITH ALCIAN BLUE AT LOW pH

  1964cited by this paper
• THE VISCERAL LESIONS OF METACHROMATIC LEUKODYSTROPHY.

  1964cited by this paper
• A note on a simple apparatus for detecting neurological deficit in rats and mice.

  1957cited by this paper

• Critical analysis of translational potential of rodent models of white matter pathology across a wide spectrum of human diseases

  2025cites this paper
• A sulfatide-centered ultra-high-resolution magnetic resonance MALDI imaging benchmark dataset for MS1-based lipid annotation tools

  2025cites this paper
• Therapeutic targeting of neuroinflammation in sphingolipidosis.

  2025cites this paper
• Chorea in Hereditary Leukodystrophies – Overview of Two Cases

  2025cites this paper
• A scoping review of stem cell models of leukodystrophies: advances in understanding pathophysiological mechanisms

  2025cites this paper
• Cross-species efficacy of AAV-mediated ARSA replacement for metachromatic leukodystrophy

  2025cites this paper
• Encapsulated cells as an enzyme replacement therapy for metachromatic leukodystrophy.

  2025cites this paper
• Deep MALDI-MS spatial omics guided by quantum cascade laser mid-infrared imaging microscopy

  2025cites this paper
• Neuraminidase 1 secondary deficiency contributes to CNS pathology in neurological mucopolysaccharidoses via brain protein hypersialylation

  2025influential citation
• Dose-response evaluation of intravenous gene therapy in a symptomatic mouse model of metachromatic leukodystrophy

  2024cites this paper
• Utilizing hiPSC-derived oligodendrocytes to study myelin pathophysiology in neuropsychiatric and neurodegenerative disorders.

  2024cites this paper
• Terra incognita of glial cell dynamics in the etiology of leukodystrophies: Broadening disease and therapeutic perspectives.

  2024cites this paper
• Lysosomal storage diseases. Sphingolipidoses – leukodystrophy

  2024cites this paper
• Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials

  2024cites this paper
• Experimental Models of CNS Disorders Related to Lysosomal Storage Diseases

  2023cites this paper
• Single Systemic Administration of a Gene Therapy Leading to Disease Treatment in Metachromatic Leukodystrophy Arsa Knock-Out Mice

  2023cites this paper
• Engineered arylsulfatase A with increased activity, stability and brain delivery for therapy of metachromatic leukodystrophy.

  2023cites this paper
• A bidirectional link between sulfatide and Alzheimer's disease.

  2023cites this paper
• Experimental Models of CNS Deficits in Lysosomal Storage Diseases

  2023cites this paper
• An in silico approach to identify early damage biomarker candidates in metachromatic leukodystrophy

  2023cites this paper
• Deep MALDI-MS Spatial ‘Omics guided by Quantum Cascade Laser Mid-infrared Imaging Microscopy

  2023cites this paper
• Models to study basic and applied aspects of lysosomal storage disorders.

  2022cites this paper
• Lipidomic analysis identifies age-disease-related changes and potential new biomarkers in brain-derived extracellular vesicles from metachromatic leukodystrophy mice

  2022influential citation
• Emerging cellular themes in leukodystrophies

  2022cites this paper
• Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A

  2021cites this paper
• Complete Correction of Brain and Spinal Cord Pathology in Metachromatic Leukodystrophy Mice

  2021cites this paper
• Formation of multinucleated globoid cells in Krabbe iPSC-derived microglia cultures: a preliminary investigation

  2021cites this paper
• Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor

  2021cites this paper
• The myelin mutant taiep rat as a model for developmental brain disorders

  2021cites this paper
• Accumulation of Seminolipid in Sertoli Cells Is Associated with Increased Levels of Reactive Oxygen Species and Male Subfertility: Studies in Aging Arsa Null Male Mice

  2021influential citation
• Sulfatide in health and disease. The evaluation of sulfatide in cerebrospinal fluid as a possible biomarker for neurodegeneration.

  2021cites this paper
• Pre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases

  2020cites this paper
• Deregulation of signalling in genetic conditions affecting the lysosomal metabolism of cholesterol and galactosyl-sphingolipids

  2020cites this paper
• Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches

  2020cites this paper
• Lipids in the Physiopathology of Hereditary Spastic Paraplegias

  2020cites this paper
• ARYLSULFATASE A-DEFICIENT MICE

  2020cites this paper
• Update on clinical ex vivo hematopoietic stem cell gene therapy for inherited monogenic diseases.

  2020cites this paper
• Lysosomal sulfatases: a growing family.

  2020cites this paper
• Leukodystrophy

  2019cites this paper
• STEPHANIE DOOVES-PROEFSCHRIFT-BINNENWERK_final.indd

  2019cites this paper
• Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective

  2019cites this paper
• Pharmacodynamic Evaluation: Gene Therapy

  2019cites this paper
• Animal models of leukodystrophy: a new perspective for the development of therapies

  2019cites this paper
• Metachromatic leukodystrophy

  2018cites this paper
• Properties, metabolism and roles of sulfogalactosylglycerolipid in male reproduction.

  2018cites this paper
• Human iPSC-based models highlight defective glial and neuronal differentiation from neural progenitor cells in metachromatic leukodystrophy

  2018cites this paper
• Biological functions of sulfoglycolipids and the EMARS method for identification of co-clustered molecules in the membrane microdomains.

  2018cites this paper
• Human iPSC-based models highlight defective glial and neuronal differentiation from neural progenitor cells in metachromatic leukodystrophy

  2018cites this paper
• This information is current as Invariant NKT Cells Autoreactivity to Sulfatide by Human Elzen

  2017cites this paper
• Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives

  2017cites this paper
• Potential of surfactant‐coated nanoparticles to improve brain delivery of arylsulfatase A

  2017cites this paper
• Hematopoietic Gene Therapies for Metabolic and Neurologic Diseases.

  2017cites this paper
• Autoreactivity to Sulfatide by Human Invariant NKT Cells

  2017cites this paper
• The lysosomal storage disease fucosidosis: towards enzyme replacement therapy

  2016cites this paper
• Inherited and acquired disorders of myelin: The underlying myelin pathology

  2016cites this paper
• Rapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus Vector

  2016cites this paper
• Bone marrow-derived macrophages and the CNS: An update on the use of experimental chimeric mouse models and bone marrow transplantation in neurological disorders.

  2016cites this paper
• Gene therapy for metachromatic leukodystrophy

  2016influential citation
• A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease

  2016cites this paper
• Progression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease

  2016cites this paper
• Stem Cell-Derived Oligodendroglial Cells for Therapy in Neurological Diseases.

  2016cites this paper
• The Journal of Clinical Investigation

  2016cites this paper
• Engineering Stem Cells for Biomedical Applications

  2016cites this paper
• Astrocytes are central in the pathomechanisms of vanishing white matter.

  2016cites this paper
• Remodeling of the plasma membrane in preparation for sperm–egg recognition: roles of acrosomal proteins

  2015cites this paper
• The Role of Saposins in Auditory and Vestibular Systems

  2015cites this paper
• Enzyme replacement in the CSF to treat metachromatic leukodystrophy in mouse model using single intracerebroventricular injection of self-complementary AAV1 vector

  2015cites this paper
• Anti-inflammatory Therapy With Simvastatin Improves Neuroinflammation and CNS Function in a Mouse Model of Metachromatic Leukodystrophy.

  2015cites this paper
• Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.

  2015cites this paper
• Spiral Ganglion Degeneration and Hearing Loss as a Consequence of Satellite Cell Death in Saposin B-Deficient Mice

  2015influential citation
• Monogenic neurological disorders of sphingolipid metabolism.

  2015cites this paper
• Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography-tandem mass spectrometry[S]

  2015cites this paper
• Mice with megalencephalic leukoencephalopathy with cysts: A developmental angle

  2015cites this paper
• Roles of Seminolipid and Its Associated Membrane Domain in Male Fertility

  2015cites this paper
• Loss of Central Auditory Processing in a Mouse Model of Canavan Disease

  2014cites this paper
• Long-term correction of biochemical and neurological abnormalities in MLD mice model by neonatal systemic injection of an AAV serotype 9 vector

  2014cites this paper
• From sheep to mice to cells: tools for the study of the sphingolipidoses.

  2014cites this paper
• Galactose-3-O-Sulfotransferase 1-4 (GAL3ST1-4) 100

  2014cites this paper
• Distribution of C16:0, C18:0, C24:1, and C24:0 sulfatides in central nervous system lipid rafts by quantitative ultra-high-pressure liquid chromatography tandem mass spectrometry.

  2014cites this paper
• Comparison of Five Peptide Vectors for Improved Brain Delivery of the Lysosomal Enzyme Arylsulfatase A

  2014cites this paper
• Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy

  2014cites this paper
• Ubiquitous Transgene Expression of the Glucosylceramide-Synthesizing Enzyme Accelerates Glucosylceramide Accumulation and Storage Cells in a Gaucher Disease Mouse Model

  2014cites this paper
• Interferons, Signal Transduction Pathways, and the Central Nervous System

  2014cites this paper
• Developing therapeutic approaches for metachromatic leukodystrophy

  2013influential citation
• Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice.

  2013cites this paper
• Development of gene therapy for blood disorders: an update.

  2013cites this paper
• Modelos animais das leucodistrofias hereditárias humanas

  2013cites this paper
• Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation.

  2013cites this paper
• Studies of pH-dependent self-association of a recombinant form of arylsulfatase A with electrospray ionization mass spectrometry and size-exclusion chromatography.

  2013cites this paper
• Advances and Pitfalls of Cell Therapy in Metabolic Leukodystrophies

  2013cites this paper
• The function of chaperone proteins in the assemblage of protein complexes involved in gamete adhesion and fusion processes.

  2013cites this paper
• Factors and processes modulating phenotypes in neuronopathic lysosomal storage diseases

  2013cites this paper
• Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age.

  2012influential citation
• Developing treatment options for metachromatic leukodystrophy.

  2012cites this paper
• More Than a Simple Lock and Key Mechanism: Unraveling the Intricacies of Sperm-Zona Pellucida Binding

  2012cites this paper
• Role of GAL3ST1 in Renal Cell Carcinoma

  2012influential citation
• Correction of Brain Oligodendrocytes by AAVrh.10 Intracerebral Gene Therapy in Metachromatic Leukodystrophy Mice

  2012cites this paper
• Inborn Metabolic Defects of Lysosomes, Peroxisomes, Carbohydrates, Fatty Acids and Mitochondria

  2012cites this paper
• Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation

  2012cites this paper
• Cyanobacteria of the Genus Prochlorothrix†

  2012cites this paper